Immunogenicity and Safety of Meningococcal Vaccine GSK 134612 Co-administered With Pneumococcal and DTPa-HBV-IPV/Hib Vaccines

GSK Investigational Site, Tallinn

GSK Investigational Site, Tallinn

GSK Investigational Site, Berlin

GSK Investigational Site, Ciudad Real

GSK Investigational Site, Berlin

GSK Investigational Site, Berlin

GSK Investigational Site, Blanes (Girona)

GSK Investigational Site, Flensburg

GSK Investigational Site, Antequera/Málaga

GSK Investigational Site, Porta Westfalica

GSK Investigational Site, Detmold

GSK Investigational Site, Baunatal-Grossenritte

GSK Investigational Site, Vellmar

GSK Investigational Site, Eschwege

GSK Investigational Site, Wanzleben

GSK Investigational Site, Seville

GSK Investigational Site, Solingen

GSK Investigational Site, Valencia

GSK Investigational Site, Valladolid

GSK Investigational Site, Kleve-Materborn

GSK Investigational Site, Tartu

GSK Investigational Site, Trier

GSK Investigational Site, Mainz

GSK Investigational Site, Frankenthal

GSK Investigational Site, Worms

GSK Investigational Site, Haabneeme

GSK Investigational Site, Schwäbisch Hall

GSK Investigational Site, Kehl

GSK Investigational Site, Munich

GSK Investigational Site, Gilching

GSK Investigational Site, Weilheim

GSK Investigational Site, Berchtesgaden

GSK Investigational Site, Kirchheim

GSK Investigational Site, Bindlach

GSK Investigational Site, Tallinn

GSK Investigational Site, Leipzig

GSK Investigational Site, Wurzen

GSK Investigational Site, Weißenfels

GSK Investigational Site, Bad Lobenstein

GSK Investigational Site, Almería

GSK Investigational Site, Badalona

GSK Investigational Site, Burgos

GSK Investigational Site, Manlleu

GSK Investigational Site, Vic